CSL has lobbed a US$11.7bn all cash public tender offer for Switzerland based specialty drug company Vifor Pharma.
The acquisition is being funded via a combination of a private placement, SPP and cash/debt, with commencement around 18 Jan-22.
CSL is under Algo Engine buy conditions and is a current holding in our ASX 100 model portfolio.
Buy between the $240 – $270 price range.
CSL is under Algo Engine buy conditions and is a current holding in our ASX 100 model portfolio.
Buy between the $240 – $270 price range.
CSL is under Algo Engine buy conditions and is a current holding in our ASX 100 model portfolio.
Buy between the $240 – $265 price range.
CSL is under Algo Engine buy conditions and is a current holding in our ASX 100 model portfolio.
CSL is under Algo Engine buy conditions and is a current holding in our ASX 100 model portfolio.
CSL is under Algo Engine buy conditions and is a current holding in our ASX 100 model portfolio.
CSL is under Algo Engine buy conditions and is a current holding in our ASX 100 model portfolio.
CSL is under Algo Engine buy conditions and is a current holding in our ASX 100 model portfolio.
CSL is under Algo Engine buy conditions and is a current holding in our ASX 100 model portfolio.
Level 17 Chifley Tower
2 Chifley Square
Sydney, NSW 2000
1300 614 002
Investor Signals Pty Ltd
ABN 44 143 555 453
Or start a free thirty day trial for our full service, which includes our ASX Research.